ISIN | CH0586376979 |
---|---|
Valor Number | 58637697 |
Bloomberg Global ID | |
Fund Name | acrevis spektrum Fund Aktien Schweiz Pt |
Fund Provider |
acrevis Bank AG
St. Gallen, Switzerland Phone: +41 58 122 75 55 E-Mail: info@acrevis.ch Web: www.acrevis.ch |
Fund Provider | acrevis Bank AG |
Representative in Switzerland | |
Distributor(s) |
acrevis Bank AG St. Gallen |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | Das Anlageziel besteht hauptsächlich darin, einen langfristigen Kapitalzuwachs verbunden mit angemessenen Erträgen zu erzielen und die Performance des im Anhang erwähnten Referenzindex (nachfolgend "Referenzindex") durch aktives Management zu übertreffen, wobei von Anlagen im Referenzindex abgewichen werden kann. |
Peculiarities |
Current Price * | 112.52 CHF | 02.09.2025 |
---|---|---|
Previous Price * | 113.79 CHF | 01.09.2025 |
52 Week High * | 119.62 CHF | 13.02.2025 |
52 Week Low * | 98.59 CHF | 09.04.2025 |
NAV * | 112.52 CHF | 02.09.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 160,138,116 | |
Unit/Share Assets *** | 227,447 | |
Trading Information SIX |
YTD Performance | +5.46% |
31.12.2024 - 02.09.2025
31.12.2024 02.09.2025 |
---|---|---|
1 month | +0.94% |
04.08.2025 - 02.09.2025
04.08.2025 02.09.2025 |
3 months | -1.71% |
02.06.2025 - 02.09.2025
02.06.2025 02.09.2025 |
6 months | -5.75% |
03.03.2025 - 02.09.2025
03.03.2025 02.09.2025 |
1 year | -2.60% |
02.09.2024 - 02.09.2025
02.09.2024 02.09.2025 |
2 years | +13.08% |
04.09.2023 - 02.09.2025
04.09.2023 02.09.2025 |
3 years | +19.87% |
02.09.2022 - 02.09.2025
02.09.2022 02.09.2025 |
5 years | +14.47% |
16.03.2021 - 02.09.2025
16.03.2021 02.09.2025 |
Equity Participation Rate in % | 99.57 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novartis AG Registered Shares | 11.65% | |
---|---|---|
Roche Holding AG | 11.22% | |
Nestle SA | 11.16% | |
Lonza Group Ltd | 5.69% | |
ABB Ltd | 5.56% | |
Zurich Insurance Group AG | 5.52% | |
Swissquote Group Holding SA | 4.93% | |
Swiss Life Holding AG | 4.59% | |
Compagnie Financiere Richemont SA Class A | 4.42% | |
Partners Group Holding AG | 4.00% | |
Last data update | 31.07.2025 |
TER | 0.90% |
---|---|
TER date | 31.10.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.50% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 31.07.2025 |